This article is a correction to:
Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry
Juan Jin
Longqiang Wang2†
Yinhua Ni
Qiang He- 1Urology & Nephrology Center, Department of Nephrology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China
- 2Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 3College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China
- 4Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, China
A Corrigendum on
Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry
By Jin J, Wang L, Liu Y, He W, Zheng D, Ni Y and He Q (2023) . 13:1018608. doi: 10.3389/fendo.2022.1018608
In the published article, there was an error in Figure 1 as published. In Figure 1B the legend of the data for T2D and T2D-DN groups were erroneously the same. The corrected Figure 1 and its caption appear below.
FIGURE 1
Figure 1 Peripheral immunity signature traits in the early-stage diabetic nephropathy patients. (A) Heatmap analysis for the overall proportions of major immune cell subsets in diabetic nephropathy (B) Pie chart characterizing the differences of major immune cell subsets proportions between T2D-DN and T2D patients. (C) Distributions of major immune cell subsets (D) The key immune cell markers for immune cell subsets are analyzed by t-SNE algorithm. (E) Statistical frequency differences of immune cell subsets between T2D-DN and T2D patients. (F) Heatmap analysis for the expressions of functional immune cell markers in the measurable immune cell subsets. Data are expressed as means ± SEM, n = 6 in T2D-DN group and n = 7 in T2D group.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: high-dimensional mass cytometry, diabetic nephropathy, immune disorder, peripheral blood mononuclear cell (PBMC), type II diabetes mellitus
Citation: Jin J, Wang L, Liu Y, He W, Zheng D, Ni Y and He Q (2023) Corrigendum: Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry. Front. Endocrinol. 14:1168889. doi: 10.3389/fendo.2023.1168889
Received: 18 February 2023; Accepted: 22 February 2023;
Published: 07 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Jin, Wang, Liu, He, Zheng, Ni and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yinhua Ni, shali0145@zjut.edu.cn; Qiang He, Qianghe1973@126.com
†These authors have contributed equally to this work